BIOTECHNOLOGY ENGLISH

バイオテクノロジー英語:必須語彙とフレーズ

研究室、規制チーム、バイオテクスタートアップのいずれで働いていても、このガイドは同僚とのコミュニケーション、レポート作成、研究発表に自信を持って取り組むために必要な英語語彙を網羅しています。

48 terms · 6 topics

分子生物学

"gene expression"

The process by which the information encoded in a gene is used to produce a functional product such as a protein

"The team measured gene expression levels using quantitative PCR to confirm that the target protein was being produced."

分子生物学

"recombinant DNA"

DNA that has been artificially created by combining genetic material from two or more sources

"The scientists inserted a human insulin gene into a bacterial plasmid to create recombinant DNA for large-scale protein production."

分子生物学

"plasmid"

A small, circular DNA molecule in a bacterium that can replicate independently of the chromosomal DNA

"The vector plasmid was transformed into E. coli cells, which then expressed the target therapeutic protein."

分子生物学

"transfection"

The introduction of foreign nucleic acids into eukaryotic cells to alter their genetic composition

"Lipid nanoparticles were used for transfection of the siRNA construct into HeLa cells to silence the oncogene."

分子生物学

"PCR (polymerase chain reaction)"

A technique used to amplify a specific segment of DNA through repeated cycles of heating and cooling

"PCR was performed to amplify the target gene fragment before ligation into the expression vector."

分子生物学

"Western blot"

A laboratory technique used to detect specific proteins in a sample after gel electrophoresis and membrane transfer

"A Western blot confirmed that the knockout cell line no longer expressed the BRCA1 protein."

分子生物学

"CRISPR-Cas9"

A genome-editing tool that allows precise modification of DNA sequences using a guide RNA and an endonuclease enzyme

"CRISPR-Cas9 was employed to introduce a point mutation in the target gene and study its effect on enzyme activity."

分子生物学

"sequencing"

The process of determining the precise order of nucleotides within a DNA or RNA molecule

"Next-generation sequencing revealed several off-target mutations introduced during the gene-editing procedure."

創薬

"lead compound"

A chemical compound that shows promise as a therapeutic agent and serves as a starting point for drug development

"After high-throughput screening, the team identified a lead compound with nanomolar potency against the target kinase."

創薬

"hit-to-lead"

The drug discovery phase in which promising screening hits are evaluated and optimised to generate lead candidates

"The hit-to-lead programme took eighteen months and reduced the initial 200 hits down to three viable lead compounds."

創薬

"ADMET"

Absorption, Distribution, Metabolism, Excretion, and Toxicity — the pharmacokinetic and safety properties of a drug candidate

"The compound failed early ADMET profiling due to poor metabolic stability in human liver microsomes."

創薬

"target engagement"

Evidence that a drug candidate interacts with and modulates its intended molecular target in a biological system

"CETSA assays were used to demonstrate target engagement of the inhibitor in live cancer cells."

創薬

"assay development"

The process of designing and validating a test system to measure the biological activity of compounds

"Robust assay development was critical before launching the high-throughput screen against the enzyme target."

創薬

"structure-activity relationship (SAR)"

The relationship between the chemical structure of a compound and its biological activity

"SAR studies guided the medicinal chemists in adding a fluorine substituent to improve potency tenfold."

創薬

"biologic"

A large, complex molecule derived from living organisms used as a therapeutic agent, such as a monoclonal antibody

"The biologic demonstrated superior efficacy compared to small-molecule inhibitors in the preclinical models."

創薬

"mode of action"

The specific biochemical interaction through which a drug produces its pharmacological effect

"Understanding the mode of action allowed the team to predict potential resistance mechanisms early in development."

臨床試験

"informed consent"

The process by which a participant voluntarily agrees to take part in a study after receiving full information about risks and benefits

"Investigators must obtain written informed consent from every participant before any study procedures begin."

臨床試験

"randomised controlled trial (RCT)"

A study design in which participants are randomly assigned to receive either the treatment or a control to reduce bias

"The Phase III randomised controlled trial enrolled 1,200 patients across 45 sites in twelve countries."

臨床試験

"placebo-controlled"

A trial design in which the control group receives an inactive substance to blind both participants and investigators to treatment allocation

"The double-blind, placebo-controlled study showed a statistically significant reduction in tumour volume at week 24."

臨床試験

"primary endpoint"

The main outcome measure pre-specified in the trial protocol that determines whether the study achieves its objective

"The primary endpoint of overall survival was met with a hazard ratio of 0.68 favouring the investigational arm."

臨床試験

"adverse event (AE)"

Any undesirable medical occurrence in a clinical trial participant, whether or not related to the study drug

"All grade 3 and above adverse events were reported to the sponsor within 24 hours of the investigator becoming aware."

臨床試験

"dose-escalation"

A clinical trial design in which successive cohorts of participants receive progressively higher doses to assess safety and determine the maximum tolerated dose

"The Phase I dose-escalation study identified 200 mg twice daily as the recommended Phase II dose."

臨床試験

"GCP (Good Clinical Practice)"

An international ethical and scientific quality standard for the design, conduct, recording, and reporting of clinical trials

"All site staff completed GCP training before the first participant was enrolled in the study."

臨床試験

"interim analysis"

A pre-planned statistical analysis conducted before the end of a trial to assess efficacy or safety at a defined time point

"The independent data monitoring committee recommended continuing the trial after a positive interim analysis at 50% of events."

薬事規制

"IND (Investigational New Drug)"

A regulatory application submitted to the FDA to request permission to test a new drug in humans before approval

"The company filed its IND application six months before the planned start of the Phase I study."

薬事規制

"BLA (Biologics License Application)"

A submission to the FDA requesting approval to market a biological product in the United States

"Following successful Phase III results, the regulatory team began compiling the BLA package for FDA submission."

薬事規制

"FDA approval"

Official authorisation from the U.S. Food and Drug Administration to market a drug or biologic for a specific indication

"The monoclonal antibody received FDA approval for second-line treatment of non-small cell lung cancer."

薬事規制

"EMA (European Medicines Agency)"

The European Union agency responsible for the scientific evaluation and supervision of medicines developed by pharmaceutical and biotech companies

"The parallel EMA and FDA review strategy was adopted to accelerate global market access for the new therapy."

薬事規制

"orphan drug designation"

A special status granted by the FDA or EMA to a drug intended to treat a rare disease, providing development incentives

"Orphan drug designation was granted for the gene therapy targeting a rare metabolic disorder affecting fewer than 10,000 patients."

薬事規制

"CMC (Chemistry, Manufacturing, and Controls)"

The section of a regulatory submission describing the composition, manufacture, and quality controls of a drug product

"The CMC team spent two years developing robust analytical methods to support the biologics licence application."

薬事規制

"breakthrough therapy designation"

An FDA programme designed to expedite development and review of drugs for serious conditions where preliminary evidence shows substantial improvement

"Breakthrough therapy designation was awarded after Phase Ib data showed an 80% overall response rate in heavily pre-treated patients."

薬事規制

"post-marketing surveillance"

The ongoing monitoring of the safety and effectiveness of a drug after it has been approved and is being used in the general population

"Post-marketing surveillance identified a rare immune-mediated adverse reaction not detected during clinical trials."

ゲノミクスとオミクス

"whole-genome sequencing (WGS)"

The process of determining the complete DNA sequence of an organism's entire genome

"Whole-genome sequencing of the patient cohort revealed a novel somatic mutation associated with therapy resistance."

ゲノミクスとオミクス

"single-cell RNA sequencing (scRNA-seq)"

A technique that measures gene expression across thousands of individual cells simultaneously

"Single-cell RNA sequencing resolved the heterogeneity of the tumour microenvironment into seven distinct cell populations."

ゲノミクスとオミクス

"proteomics"

The large-scale study of all proteins expressed by a cell, tissue, or organism at a given time

"Proteomics analysis identified twenty differentially expressed proteins in treated versus untreated liver cancer cells."

ゲノミクスとオミクス

"biomarker"

A measurable indicator of a biological state or condition that can be used for diagnosis, prognosis, or to predict treatment response

"PD-L1 expression level was validated as a predictive biomarker for response to the checkpoint inhibitor therapy."

ゲノミクスとオミクス

"copy number variation (CNV)"

Differences in the number of copies of a particular segment of DNA among individuals

"Array comparative genomic hybridisation detected high-level amplification of the ERBB2 locus, indicating copy number variation in the tumour."

ゲノミクスとオミクス

"epigenomics"

The study of chemical modifications to DNA and histone proteins that regulate gene expression without altering the DNA sequence

"Epigenomics profiling revealed widespread hypermethylation of tumour suppressor gene promoters in the patient samples."

ゲノミクスとオミクス

"metagenomics"

The study of genetic material recovered directly from environmental or biological samples without prior cultivation of individual organisms

"Metagenomics of gut microbiome samples identified microbial signatures associated with improved immunotherapy outcomes."

ゲノミクスとオミクス

"pathway analysis"

A bioinformatics approach used to identify which biological pathways are significantly enriched or affected in a dataset

"Pathway analysis of the differentially expressed genes highlighted dysregulation of the PI3K-AKT-mTOR signalling network."

研究室運営とスケールアップ

"upstream processing"

The stages of biopharmaceutical manufacturing that involve growing cells and producing the biological molecule of interest

"The upstream processing team optimised the fed-batch culture conditions to increase monoclonal antibody titre to 8 g/L."

研究室運営とスケールアップ

"downstream processing"

The stages of biopharmaceutical manufacturing that involve isolating, purifying, and formulating the final product

"Downstream processing using Protein A chromatography achieved a purity of greater than 99.5% for the therapeutic antibody."

研究室運営とスケールアップ

"bioreactor"

A vessel or system in which biological reactions are carried out under controlled conditions for the production of biological products

"Cell density in the 2,000-litre bioreactor was monitored online using capacitance probes throughout the production run."

研究室運営とスケールアップ

"GMP (Good Manufacturing Practice)"

A system of regulations ensuring that products are consistently produced and controlled according to quality standards

"The manufacturing facility received GMP certification from the EMA before the first commercial batch was released."

研究室運営とスケールアップ

"cell bank"

A repository of cells stored under controlled conditions that serves as the source material for biopharmaceutical production

"A master cell bank and working cell bank were established and fully characterised prior to initiating process development."

研究室運営とスケールアップ

"yield"

The amount of product obtained from a given manufacturing process, often expressed as a percentage of the theoretical maximum

"Process optimisation increased the overall yield from 45% to 72%, significantly reducing the cost of goods."

研究室運営とスケールアップ

"technology transfer"

The process of moving a manufacturing process from one site or organisation to another while maintaining product quality

"Technology transfer from the development laboratory to the contract manufacturing organisation took nine months."

研究室運営とスケールアップ

"contamination control"

Procedures and practices designed to prevent unwanted microorganisms or substances from compromising a biological process or product

"Stringent contamination control protocols, including regular environmental monitoring, ensured no microbial deviations over twelve production campaigns."

よくある質問

バイオテクノロジーの専門家に英語が重要な理由は?

英語は科学とバイオテクノロジーのグローバル言語です。研究論文、規制ガイドライン、学会発表、特許申請の大半が英語で書かれています。英語を流暢に読み書き話せるプロフェッショナルは、そうでない人に比べてはるかに多くのリソースとキャリア機会にアクセスできます。

バイオテクノロジーで英語を使うにはどんな語彙が必要ですか?

主要な分野には、分子生物学の手法(PCR、CRISPR、シーケンシング)、創薬の用語(ADMET、リード最適化、SAR)、臨床試験の言語(エンドポイント、有害事象、GCP)、規制語彙(IND、BLA、FDA)、ゲノミクスの用語(バイオマーカー、パスウェイ解析)が含まれます。

バイオテクノロジーのプロフェッショナル英語を習得するにはどのくらいかかりますか?

中級の一般英語(B1〜B2レベル)を持つ専門家のほとんどは、3〜6ヶ月の継続的な練習でバイオテクノロジーの主要語彙に慣れることができます。単語リストを暗記するだけでなく、論文・発表・動画などの本物の科学的コミュニケーションに触れることが鍵です。

バイオテクノロジー英語を学ぶ最善の方法は何ですか?

最も効果的なアプローチは、技術的な読み物(ジャーナル論文、FDAガイダンス文書)と、学会講演・ウェビナー・バイオテクドキュメンタリーなどの実際の英語を聞くことを組み合わせることです。現在のレベルより少し上の「理解可能なインプット」は、孤立した用語の暗記よりはるかに速く語彙習得を加速させます。

動画でバイオテクノロジー英語を学べますか?

もちろんです。学会発表(AACR、ASHP、BIO Internationalなど)の視聴、科学ポッドキャストのリスニング、創薬に関するドキュメンタリーコンテンツの視聴は、自然に語彙を吸収する優れた方法です。ノートを取りながら行えば、読むだけよりもはるかに効果的に用語を定着させることができます。

プロフェッショナル英語を吸収する最も速い方法は、あなたのレベルに合った本物のコンテンツによる理解可能なインプットです。

実際の動画で練習する →